Assembly Bio prices USD 100 million follow-on offering at USD 26.5 per share

Assembly Biosciences, Inc.

ASMB

0.00

Assembly Biosciences priced a registered underwritten follow-on offering expected to raise about USD 100 million in gross proceeds.
Deal includes 3,358,602 common shares priced at USD 26.5, with pre-funded warrants covering up to 415,000 shares priced at USD 26.5 with a USD 0.001 per-share exercise price.
Underwriters received a 30-day option to buy up to 566,040 additional shares.
Closing is expected on or about May 26, 2026, subject to customary conditions.
Net proceeds are slated for clinical development of pipeline candidates, with the balance for general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Assembly Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605220705PRIMZONEFULLFEED9725303) on May 22, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.